Diabetes Care 35:12251231 Russell-Jones D, Cuddihy RM, Hanefeld M et al (2012) Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study
This combination approach has gained recognition for dramatically accelerating recovery from both acute injuries and chronic pain conditions
Why people use it: Most people interested in AOD-9604 are those whove previously tried semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) and want to transition to something else, often due to side effects
Suggested Use: 1-2 capsules per day, in divided doses, between meals
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management
DOI: 10.1111/obr.12436 Hiatt WR, Regensteiner JG, Creager MA, et al